CN106456603B - 软性抗胆碱能药类似物的制剂 - Google Patents

软性抗胆碱能药类似物的制剂 Download PDF

Info

Publication number
CN106456603B
CN106456603B CN201580013622.0A CN201580013622A CN106456603B CN 106456603 B CN106456603 B CN 106456603B CN 201580013622 A CN201580013622 A CN 201580013622A CN 106456603 B CN106456603 B CN 106456603B
Authority
CN
China
Prior art keywords
composition
hydroxyacetoxy
cyclopentyl
phenyl
bromide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580013622.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN106456603A (zh
Inventor
N·S·博多尔
J·J·科伦
D·安古洛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bodor Laboratories Inc
Original Assignee
Bodor Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bodor Laboratories Inc filed Critical Bodor Laboratories Inc
Priority to CN201910812881.XA priority Critical patent/CN110420167B/zh
Priority to CN201911319136.8A priority patent/CN110917124B/zh
Publication of CN106456603A publication Critical patent/CN106456603A/zh
Application granted granted Critical
Publication of CN106456603B publication Critical patent/CN106456603B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
CN201580013622.0A 2014-03-13 2015-03-12 软性抗胆碱能药类似物的制剂 Active CN106456603B (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201910812881.XA CN110420167B (zh) 2014-03-13 2015-03-12 软性抗胆碱能药类似物的制剂
CN201911319136.8A CN110917124B (zh) 2014-03-13 2015-03-12 软性抗胆碱能药类似物的制剂

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461952505P 2014-03-13 2014-03-13
US61/952,505 2014-03-13
US14/285,488 2014-05-22
US14/285,488 US20150259283A1 (en) 2014-03-13 2014-05-22 Formulation for soft anticholinergic analogs
PCT/US2015/020253 WO2015138776A1 (en) 2014-03-13 2015-03-12 Formulation for soft anticholinergic analogs

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CN201910812881.XA Division CN110420167B (zh) 2014-03-13 2015-03-12 软性抗胆碱能药类似物的制剂
CN201911319136.8A Division CN110917124B (zh) 2014-03-13 2015-03-12 软性抗胆碱能药类似物的制剂

Publications (2)

Publication Number Publication Date
CN106456603A CN106456603A (zh) 2017-02-22
CN106456603B true CN106456603B (zh) 2020-01-10

Family

ID=54068191

Family Applications (3)

Application Number Title Priority Date Filing Date
CN201580013622.0A Active CN106456603B (zh) 2014-03-13 2015-03-12 软性抗胆碱能药类似物的制剂
CN201910812881.XA Active CN110420167B (zh) 2014-03-13 2015-03-12 软性抗胆碱能药类似物的制剂
CN201911319136.8A Active CN110917124B (zh) 2014-03-13 2015-03-12 软性抗胆碱能药类似物的制剂

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN201910812881.XA Active CN110420167B (zh) 2014-03-13 2015-03-12 软性抗胆碱能药类似物的制剂
CN201911319136.8A Active CN110917124B (zh) 2014-03-13 2015-03-12 软性抗胆碱能药类似物的制剂

Country Status (20)

Country Link
US (8) US20150259283A1 (cg-RX-API-DMAC7.html)
EP (1) EP3116498B1 (cg-RX-API-DMAC7.html)
JP (5) JP6293919B2 (cg-RX-API-DMAC7.html)
KR (4) KR102586868B1 (cg-RX-API-DMAC7.html)
CN (3) CN106456603B (cg-RX-API-DMAC7.html)
AU (2) AU2015229243B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016021011B1 (cg-RX-API-DMAC7.html)
CA (1) CA2941649C (cg-RX-API-DMAC7.html)
DK (2) DK3116498T3 (cg-RX-API-DMAC7.html)
ES (1) ES2710292T3 (cg-RX-API-DMAC7.html)
HU (1) HUE041868T2 (cg-RX-API-DMAC7.html)
IL (1) IL247571B (cg-RX-API-DMAC7.html)
MX (1) MX369129B (cg-RX-API-DMAC7.html)
MY (1) MY183531A (cg-RX-API-DMAC7.html)
PH (1) PH12016501732B1 (cg-RX-API-DMAC7.html)
PL (1) PL3116498T3 (cg-RX-API-DMAC7.html)
PT (2) PT3116498T (cg-RX-API-DMAC7.html)
SG (1) SG11201607480SA (cg-RX-API-DMAC7.html)
WO (1) WO2015138776A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201607071B (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070110402A (ko) * 2005-03-03 2007-11-16 레반스 테라퓨틱스 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법
ES2658897T3 (es) 2011-08-24 2018-03-12 Novan, Inc. Macromoléculas de liberación de óxido nítrico ajustables que tienen múltiples estructuras donantes de óxido nítrico
EP3030266B1 (en) 2013-08-08 2020-10-28 Novan Inc. Topical compositions and methods of using the same
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
HK1253236A1 (zh) 2015-07-21 2019-06-14 博多尔实验仪器公司 软性抗胆碱能药类似物的制剂
TWI719046B (zh) * 2016-07-21 2021-02-21 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
US11381304B2 (en) * 2017-08-30 2022-07-05 Iridium Satellite Llc Satellite communications with multiple classes of terrestrial terminal devices
WO2019217926A1 (en) * 2018-05-11 2019-11-14 Brickell Biotech, Inc. Applicator and system for pharmaceutical preparation and method of use
WO2020235665A1 (en) * 2019-05-23 2020-11-26 Kaken Pharmaceutical Co., Ltd. Crystalline form of sofpironium bromide and preparation method thereof
SG10201912063PA (en) * 2019-12-12 2021-07-29 Nat Skin Centre Singapore Pte Ltd A pharmaceutical formulation
US20230149349A1 (en) * 2020-03-03 2023-05-18 Kaken Pharmaceutical Co., Ltd. Medicament containing sofpironium bromide
TWI925832B (zh) 2020-03-03 2026-05-21 日商科研製藥股份有限公司 原發性腋窩多汗症的治療方法及其醫藥
KR102655121B1 (ko) 2021-09-17 2024-04-08 한국식품연구원 락토바실러스 사케이 k040706 균주 검출용 프라이머 세트 및 이의 용도
US11807604B1 (en) * 2022-02-16 2023-11-07 Miralogx Llc Pharmaceutical compounds, pharmaceutical compositions, and methods of treating asthma and other disorders
WO2024026412A1 (en) * 2022-07-28 2024-02-01 Tff Pharmaceuticals, Inc. Thin film freezing methods and compositions formulated from dispersed active agents
KR102611847B1 (ko) * 2023-03-27 2023-12-12 주식회사 이플라스크 무스카린 수용체 길항 활성을 갖는 신규한 피롤리디늄 화합물 및 이의 용도

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101048126A (zh) * 2004-10-25 2007-10-03 荷兰联合利华有限公司 具有二羟丙基三（c1－c3烷基）铵单取代多元醇的盐的个人护理组合物
US7399861B2 (en) * 2005-11-10 2008-07-15 Bodor Nicholas S Soft anticholinergic esters

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK149832C (da) * 1981-07-17 1987-05-18 Riemann Claus Antiperspirantpraeparat bestaaende af to komponenter
DK483587D0 (da) * 1987-09-15 1987-09-15 Riemann & Co Aps Claus Antiperspirant praeparat
US5292530A (en) * 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
CA2014633C (en) * 1989-06-02 2000-07-18 Andrew D. Mccrea Stable anhydrous compositions for topical delivery of active materials
US5232689A (en) * 1990-12-21 1993-08-03 Dow Corning Corporation Translucent antiperspirant compositions
US5143719A (en) 1991-04-16 1992-09-01 Chesebrough-Pond's Usa Co. Anticalculus oral composition containing combinations of organophosphorus polycarboxylate cotelomers and inorganic polyphosphate salts
GB2280111B (en) 1993-07-16 1997-05-07 Union Camp Corp Clear gel antiperpirant compositions
US5895644A (en) * 1997-11-20 1999-04-20 Colgate-Palmolive Company Clear antiperspirant stick with dibenzylidene sorbitol and guar and process of making same
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
US6319491B1 (en) 2000-04-11 2001-11-20 Michael B. Whipple Anti-sweat lotion
CA2461696A1 (en) * 2001-09-26 2003-04-03 Alison B. Lukacsko Compositions and methods for inhibiting eccrine perspiration in humans
JP2003113392A (ja) 2001-10-04 2003-04-18 Kiyomitsu Kawasaki 芳香・消臭組成物および該芳香・消臭組成物を含有する人体用芳香・消臭剤
US8252316B2 (en) * 2002-05-03 2012-08-28 Purepharm Inc. Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
BR0308051A (pt) 2003-12-15 2005-09-06 Natura Cosmeticos Sa Composição base para preparação de formulações multifuncionais para o cuidado e proteção da pele e cabelo
US20060088496A1 (en) * 2004-10-25 2006-04-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions with salts of hydroxypropyl trialkylammonium substituted mono-saccharide
GB0428416D0 (en) * 2004-12-24 2005-02-02 Novartis Ag Organic compounds
GB0428418D0 (en) * 2004-12-24 2005-02-02 Novartis Ag Organic compounds
BRPI0519481A2 (pt) * 2004-12-27 2009-02-03 Beiersdorf Ag glicopirrolato em preparaÇÕes cosmÉticas
WO2007046102A2 (en) * 2005-10-19 2007-04-26 Menni Menashe Zinger Methods for the treatment of hyperhidrosis
ATE529399T1 (de) * 2005-11-10 2011-11-15 Nicholas S Bodor Sanfte anticholinerge ester
AU2006201878A1 (en) * 2006-03-13 2007-09-27 Foamix Ltd Foamable composition for hyperhidrosis
JP5371235B2 (ja) * 2006-12-06 2013-12-18 ロート製薬株式会社 皮膚外用剤
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
US8618160B2 (en) 2007-10-18 2013-12-31 Rose U Topical glycopyrrolate formulations
US20100137357A1 (en) * 2008-11-26 2010-06-03 Koleng John J Compositions and methods for hyperhidrosis
US20140037713A1 (en) * 2012-08-03 2014-02-06 Antares Pharma Ipl, Ag Transdermal compositions for anti-cholinergic agents
JP6223543B2 (ja) * 2013-03-15 2017-11-01 ボドール ラボラトリーズ， インコーポレイテッド 多汗症の処置のための抗コリン作用性グリコピロレートエステル
WO2015138700A1 (en) 2014-03-13 2015-09-17 Bodor Laboratories, Inc. Use of selected anticholinergic zwitterions
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
HK1253236A1 (zh) 2015-07-21 2019-06-14 博多尔实验仪器公司 软性抗胆碱能药类似物的制剂
TWI719046B (zh) 2016-07-21 2021-02-21 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101048126A (zh) * 2004-10-25 2007-10-03 荷兰联合利华有限公司 具有二羟丙基三（c1－c3烷基）铵单取代多元醇的盐的个人护理组合物
US7399861B2 (en) * 2005-11-10 2008-07-15 Bodor Nicholas S Soft anticholinergic esters

Also Published As

Publication number Publication date
MY183531A (en) 2021-02-25
CN110420167B (zh) 2023-02-17
US20150320722A1 (en) 2015-11-12
US12398102B2 (en) 2025-08-26
MX369129B (es) 2019-10-30
US20210087142A1 (en) 2021-03-25
KR20260114591A (ko) 2026-07-22
ZA201607071B (en) 2018-12-19
JP6756763B2 (ja) 2020-09-16
US20200113869A1 (en) 2020-04-16
CN110917124B (zh) 2023-06-20
MX2016011529A (es) 2016-12-07
KR102586868B1 (ko) 2023-10-11
AU2015229243A1 (en) 2016-10-20
US11084788B2 (en) 2021-08-10
BR112016021011A8 (pt) 2021-07-20
US20210198195A1 (en) 2021-07-01
AU2019257421A1 (en) 2019-11-21
JP2017214429A (ja) 2017-12-07
IL247571B (en) 2020-03-31
ES2710292T3 (es) 2019-04-24
JP2018115203A (ja) 2018-07-26
US20170020845A1 (en) 2017-01-26
PH12016501732A1 (en) 2017-02-06
US10947192B2 (en) 2021-03-16
BR112016021011B1 (pt) 2022-12-13
CN110420167A (zh) 2019-11-08
US20150259283A1 (en) 2015-09-17
EP3116498A4 (en) 2017-11-08
IL247571A0 (en) 2016-11-30
US11034652B2 (en) 2021-06-15
CN106456603A (zh) 2017-02-22
CA2941649C (en) 2021-03-02
SG11201607480SA (en) 2016-10-28
EP3116498B1 (en) 2018-12-12
PT3325487T (pt) 2021-07-29
AU2019257421B2 (en) 2021-10-21
DK3116498T3 (en) 2019-03-11
JP2019189650A (ja) 2019-10-31
JP2017507970A (ja) 2017-03-23
US20200093791A1 (en) 2020-03-26
US10961191B2 (en) 2021-03-30
PT3116498T (pt) 2019-02-11
KR102987841B1 (ko) 2026-07-08
US20210078946A1 (en) 2021-03-18
WO2015138776A1 (en) 2015-09-17
KR102433868B1 (ko) 2022-08-19
KR20160133492A (ko) 2016-11-22
AU2015229243B2 (en) 2019-11-21
KR20220119517A (ko) 2022-08-29
JP2020079321A (ja) 2020-05-28
JP6762047B2 (ja) 2020-09-30
JP6293919B2 (ja) 2018-03-14
PH12016501732B1 (en) 2017-02-06
JP6461267B2 (ja) 2019-01-30
CN110917124A (zh) 2020-03-27
KR20230145522A (ko) 2023-10-17
PL3116498T3 (pl) 2019-05-31
CA2941649A1 (en) 2015-09-17
BR112016021011A2 (pt) 2017-08-15
HUE041868T2 (hu) 2019-05-28
DK3325487T3 (da) 2021-08-02
EP3116498A1 (en) 2017-01-18

Similar Documents

Publication Publication Date Title
CN110420167B (zh) 软性抗胆碱能药类似物的制剂
KR102762010B1 (ko) 연성 항콜린제 유사체를 위한 제제
HK40026881A (en) Formulation for soft anticholinergic analogs
HK40026881B (en) Formulation for soft anticholinergic analogs
HK1233922B (en) Formulation for soft anticholinergic analogs
HK40016903A (zh) 软性抗胆碱能药类似物的制剂
HK40016903B (en) Formulation for soft anticholinergic analogs
HK1233922A1 (en) Formulation for soft anticholinergic analogs
HK40119619A (en) Formulation for soft anticholinergic analogs
HK40119620A (en) Formulation for soft anticholinergic analogs
HK40119997A (en) Formulation for soft anticholinergic analogs
HK1233505B (en) Formulation for soft anticholinergic analogs
HK1233505A1 (en) Formulation for soft anticholinergic analogs

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1233922

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant